Steward Partners Investment Advisory, LLC Adamis Pharmaceuticals Corp Transaction History

Steward Partners Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 17, 2020	SELL	$0.51 - $1.26 $510 - $1,260	-1,000 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$1.26 - $2.23 $1,260 - $2,230	1,000 New	1,000 $1,000
Q4 2018 Jan 15, 2019	SELL	$2.1 - $3.21 $1,932 - $2,953	-920 Closed	0 $0
Q3 2018 Oct 23, 2018	SELL	$2.25 - $4.8 $3,937 - $8,400	-1,750 Reduced 65.54%	920 $3,000
Q1 2018 Apr 20, 2018	SELL	$2.55 - $4.85 $765 - $1,455	-300 Reduced 10.1%	2,670 $9,000
Q4 2017 Jan 19, 2018	BUY	$3.5 - $5.65 $10,395 - $16,780	2,970	2,970 $13,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.